Archived | Autism Speaks: Clinical Trials Network | Circa 2007 #NotAnAutisticAlly

Clinical Trials Network Fluoxetine StudyMemantine Study Autism Speaks' Clinical Trials Network (CTN) was officially launched in 2005 by Cure Autism Now to focus on translational research, the critical step necessary to transfer findings from the laboratory to clinical application. Well controlled and appropriately blinded studies are needed to test whether anecdotal evidence holds. By facilitating …

Archived | Autism Speaks: Environmental Factors in Autism Initiative | Circa December 2007

Environmental Factors in Autism Initiative The role of environmental factors in the development of autism is a crucial area of study. Although we know that genetics is an important factor, genetics alone may not account for all cases of autism. The increase in the reported number of autism cases has generated extreme concern over the …

Archived | Cure Autism Now/Autism Speaks: Isaac Pessah, Ph.D. Receives Inaugural CAN Environmental Innovator Award | Circa 2007 #NotAnAutisticAlly

Isaac Pessah, Ph.D. Receives Inaugural CAN Environmental Innovator Award Cure Autism Now (CAN) is pleased to name Isaac Pessah, Ph.D., as recipient of its first CAN Environmental Innovator Award. This award was designed to identify and support researchers who are studying how relevant exposures to toxins translate into altered biology, and how this is related to …

Archived | Cure Autism Now/Autism Speaks: Autism, Autism, Autism: Finding Answers within the Vaccine | Circa 2007 #NotAnAutisticAlly

Peter Bell from Cure Autism Now and later, Autism Speaks Autism, Autism, Autism: Finding Answers within the Vaccine  A Letter from Cure Autism Now's Board Chair and CEOAutism, autism, autism. It has permeated everything. We have read and heard the word "autism" from so many people and in so many news articles lately, it is …

Archived | Autism Speaks: Nationwide Resource Database Launched | Circa May 2007 #NotAnAutisticAlly

Nationwide Resource Database Launched  Autism Speaks has released a highly anticipated online comprehensive nationwide resource database, providing individuals and families with local resources that service a variety of needs from early intervention through adult care. This inclusive database, overseen by the Family Services Committee, provides users with information such as health care facilities, educational services, …

Archived | Autism Speaks: New England Journal of Medicine Reports No Causal Association Between Thimerosal and Neuropsychological Functioning | Circa September 2007 #NotAnAutisticAlly

A new study entitled "Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years" has been published in the New England Journal of Medicine, vol. 357 no. 13.  ABSTRACT BackgroundIt has been hypothesized that early exposure to thimerosal, a mercury-containing preservative used in vaccines and immune globulin preparations, is associated with neuropsychological deficits in children.  …

Archived | Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures Are Harmless, State SafeMinds | Circa September 26, 2007 #NotAnAutisticAlly #Pseudoscience

Contact: Cheri Jacobus202/547-7358Sallie Bernard970/544-3466sbernard@safeminds.org SafeMinds Press ReleaseWednesday, September 26, 2007 Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures Are Harmless, State SafeMinds "Study Findings and Limitations Require Further Investigations," Says Dissenting Panel Member ATLANTA, GA – A Centers for Disease Control (CDC) study on the relationship between mercury (thimerosal) in vaccines and …